Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
2009 Standout
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry
2000
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
2009
Psoriasis
2009 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
p53-Mdm2--the affair that never ends
2002
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
2012
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
2015
ATP drives lamina propria TH17 cell differentiation
2008 Nature
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
2008
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
2008 StandoutNature
Role of Gadd45 in apoptosis
2000
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
The p53 pathway
1999
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
DNA damage induces phosphorylation of the amino terminus of p53
1997
Regulation of c-Myc through Phosphorylation at Ser-62 and Ser-71 by c-Jun N-Terminal Kinase
1999
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
2011
Immunity, Inflammation, and Cancer
2010 Standout
Systemic Lupus Erythematosus
2011 Standout
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
2011
Chk2 Oligomerization Studied by Phosphopeptide Ligation
2008 StandoutNobel
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
2015
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
c-Jun NH2-terminal Kinases Target the Ubiquitination of Their Associated Transcription Factors
1997
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
The DNA damage response: putting checkpoints in perspective
2000 StandoutNature
Mechanisms of switching on p53: a role for covalent modification?
1999
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
2010
Tumour necrosis factor and cancer
2009
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Deciphering the role of Th17 cells in human disease
2011
JNK targets p53 ubiquitination and degradation in nonstressed cells
1998
Responses to immune checkpoint inhibitors in nonagenarians
2016
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
2001 Standout
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
2001 Standout
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Regulation of JNK signaling by GSTp
1999
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
The Th17 Pathway and Inflammatory Diseases of the Intestines, Lungs, and Skin
2011
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
2017
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
2000 StandoutScience
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody
2014
IL-17 and Th17 Cells
2009 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases
2006
Cytokine Storm
2020 Standout
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
1998 StandoutScience
Surfing the p53 network
2000 StandoutNature
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
2003 StandoutNobel
MEKK1/JNK signaling stabilizes and activates p53
1998
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
2000
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
1998 StandoutScience
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Free Radicals in the Physiological Control of Cell Function
2002 Standout
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Works of Mark J. Bluth being referenced
Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies
2014
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
2016
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
2007
Myeloid Dendritic Cells from Human Cutaneous Squamous Cell Carcinoma Are Poor Stimulators of T-Cell Proliferation
2009
Langerhans Cells from Human Cutaneous Squamous Cell Carcinoma Induce Strong Type 1 Immunity
2012
Conformation-dependent phosphorylation of p53
1997
Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas.
2014
Clinical activity of ipilimumab for metastatic uveal melanoma
2013
Ipilimumab for Patients With Advanced Mucosal Melanoma
2013